newsfilter
← Latest News
ClinicalTrials.gov·

A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy - NCT04998812

Proportion of infants with B cell levels (CD19+ cells) below the lower limit of normal (LLN), B cell levels (CD19+ cells) in the infant, Serum concentration of ocrelizumab in the umbilical cord blood at birth, (and 10 more...)